HK Stock MarketDetailed Quotes

INNOCARE (09969)

Watchlist
  • 13.830
  • +0.110+0.80%
Market Closed Apr 30 16:07 CST
24.37BMarket Cap29.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

INNOCARE (09969) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Turnover
38.65%528.63M
135.27%2.37B
59.85%1.12B
74.26%731.43M
129.92%381.26M
36.68%1.01B
29.85%697.75M
11.17%419.74M
-12.44%165.82M
18.09%738.54M
Operating income
38.65%528.63M
135.27%2.37B
59.85%1.12B
74.26%731.43M
129.92%381.26M
36.68%1.01B
29.85%697.75M
11.17%419.74M
-12.44%165.82M
18.09%738.54M
Cost of sales
----
-38.05%-191.11M
----
-27.56%-76.71M
----
-7.79%-138.44M
----
20.94%-60.14M
----
10.43%-128.44M
Operating expenses
-73.90%-62.72M
-38.05%-191.11M
-27.70%-125.18M
-27.56%-76.71M
-48.48%-36.07M
-7.79%-138.44M
2.83%-98.03M
20.94%-60.14M
43.38%-24.29M
10.43%-128.44M
Gross profit
34.97%465.9M
150.72%2.18B
65.10%990.15M
82.07%654.72M
143.90%345.2M
42.76%871.01M
37.40%599.72M
19.28%359.6M
-3.38%141.53M
26.58%610.1M
Selling expenses
-4.20%-118.8M
-38.10%-579.96M
-40.77%-385.6M
-55.31%-244.07M
-27.34%-114.01M
-14.46%-419.96M
-2.48%-273.93M
17.81%-157.15M
-4.15%-89.53M
16.35%-366.89M
Administrative expenses
-2.07%-43.65M
-10.69%-203.51M
-3.33%-130M
-3.55%-94.76M
-0.83%-42.76M
4.99%-183.86M
1.66%-125.82M
-4.82%-91.51M
-14.89%-42.41M
-6.59%-193.52M
Research and development expenses
-10.38%-229.16M
-16.90%-951.62M
-9.93%-676.05M
-6.86%-449.7M
-16.81%-207.6M
-8.37%-814.03M
-11.87%-614.98M
-17.51%-420.82M
-26.09%-177.73M
-17.53%-751.18M
Profit from asset sales
----
----
--3.4K
----
--3.4K
----
----
----
----
----
Revaluation surplus
29.94%3.33M
----
117.32%5.09M
----
115.54%2.56M
45.13%-29.61M
-25.31%-29.42M
0.19%-23.66M
-155.08%-16.48M
-1,689.02%-53.96M
-Changes in the fair value of other assets
29.94%3.33M
----
117.32%5.09M
----
115.54%2.56M
45.13%-29.61M
-25.31%-29.42M
0.19%-23.66M
-155.08%-16.48M
-1,689.02%-53.96M
Impairment and provision
-1,791.84%-858.6K
72.31%-414K
119.88%136K
121.86%146K
--50.75K
-457.84%-1.5M
-2,211.70%-683.96K
---668K
----
-168.00%-268K
-Other impairment is provision
-1,791.84%-858.6K
72.31%-414K
119.88%136K
121.86%146K
--50.75K
-457.84%-1.5M
-2,211.70%-683.96K
---668K
----
-168.00%-268K
Special items of operating profit
-29.93%11.53M
59.23%261.77M
214.42%72.45M
66.93%130.7M
106.31%16.46M
8.53%164.4M
-10.29%23.04M
263.51%78.3M
-23.51%7.98M
262.94%151.48M
Operating profit
1,263.69%82.56M
271.70%710.07M
67.74%-139.64M
98.84%-2.96M
96.05%-7.09M
31.56%-413.55M
15.62%-432.81M
37.08%-255.92M
-55.37%-179.67M
30.30%-604.24M
Financing income
-25.29%25.22M
----
-34.38%90.93M
----
-28.38%33.75M
----
-3.54%138.56M
----
2.15%47.13M
----
Financing cost
-6.40%-14.38M
-60.21%-54.13M
-102.91%-41.71M
-160.11%-27.22M
-161.10%-13.52M
3.65%-33.79M
32.62%-20.56M
48.56%-10.47M
50.03%-5.18M
-105.74%-35.07M
Share of profit from joint venture company
----
96.27%-196K
----
73.96%-400K
----
-7.35%-5.26M
----
26.40%-1.54M
----
49.54%-4.9M
Special items of earning before tax
--325.04K
----
7,855.69%510.87K
----
----
----
-100.07%-6.59K
----
4,957.94%31K
----
Earning before tax
539.55%104.85M
244.89%655.74M
77.50%-64.18M
88.59%-30.58M
111.25%16.39M
29.74%-452.59M
47.10%-285.29M
37.57%-267.92M
-923.66%-145.66M
27.92%-644.21M
Tax
----
-4,294.68%-11.56M
----
-17,331.03%-5.06M
----
81.56%-263K
----
---29K
----
---1.43M
After-tax profit from continuing operations
607.72%102.45M
242.25%644.18M
74.78%-71.95M
86.70%-35.64M
109.94%14.48M
29.86%-452.86M
47.09%-285.32M
37.57%-267.95M
-923.66%-145.66M
27.76%-645.63M
Earning after tax
607.72%102.45M
242.25%644.18M
74.78%-71.95M
86.70%-35.64M
109.94%14.48M
29.86%-452.86M
47.09%-285.32M
37.57%-267.95M
-923.66%-145.66M
27.76%-645.63M
Minority profit
3.47%-3.37M
114.03%1.72M
23.94%-7.54M
9.24%-5.55M
-7.22%-3.49M
14.93%-12.22M
-21.99%-9.91M
12.35%-6.11M
-78.67%-3.26M
-101.42%-14.37M
Profit attributable to shareholders
488.93%105.82M
245.81%642.47M
76.61%-64.41M
88.51%-30.09M
112.62%17.97M
30.20%-440.63M
48.15%-275.41M
37.98%-261.84M
-1,047.82%-142.4M
28.80%-631.26M
Basic earnings per share
500.00%0.06
246.15%0.38
75.00%-0.04
87.50%-0.02
112.50%0.01
29.73%-0.26
48.39%-0.16
36.00%-0.16
-700.00%-0.08
38.33%-0.37
Diluted earnings per share
500.00%0.06
246.15%0.38
75.00%-0.04
87.50%-0.02
112.50%0.01
29.73%-0.26
48.39%-0.16
36.00%-0.16
-700.00%-0.08
38.33%-0.37
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
CAS (2007)
HKAS
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
--
--
Ernst & Young Huaming Accounting Firm (Special General Partnership)
--
--
--
Ernst & Young
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Turnover 38.65%528.63M135.27%2.37B59.85%1.12B74.26%731.43M129.92%381.26M36.68%1.01B29.85%697.75M11.17%419.74M-12.44%165.82M18.09%738.54M
Operating income 38.65%528.63M135.27%2.37B59.85%1.12B74.26%731.43M129.92%381.26M36.68%1.01B29.85%697.75M11.17%419.74M-12.44%165.82M18.09%738.54M
Cost of sales -----38.05%-191.11M-----27.56%-76.71M-----7.79%-138.44M----20.94%-60.14M----10.43%-128.44M
Operating expenses -73.90%-62.72M-38.05%-191.11M-27.70%-125.18M-27.56%-76.71M-48.48%-36.07M-7.79%-138.44M2.83%-98.03M20.94%-60.14M43.38%-24.29M10.43%-128.44M
Gross profit 34.97%465.9M150.72%2.18B65.10%990.15M82.07%654.72M143.90%345.2M42.76%871.01M37.40%599.72M19.28%359.6M-3.38%141.53M26.58%610.1M
Selling expenses -4.20%-118.8M-38.10%-579.96M-40.77%-385.6M-55.31%-244.07M-27.34%-114.01M-14.46%-419.96M-2.48%-273.93M17.81%-157.15M-4.15%-89.53M16.35%-366.89M
Administrative expenses -2.07%-43.65M-10.69%-203.51M-3.33%-130M-3.55%-94.76M-0.83%-42.76M4.99%-183.86M1.66%-125.82M-4.82%-91.51M-14.89%-42.41M-6.59%-193.52M
Research and development expenses -10.38%-229.16M-16.90%-951.62M-9.93%-676.05M-6.86%-449.7M-16.81%-207.6M-8.37%-814.03M-11.87%-614.98M-17.51%-420.82M-26.09%-177.73M-17.53%-751.18M
Profit from asset sales ----------3.4K------3.4K--------------------
Revaluation surplus 29.94%3.33M----117.32%5.09M----115.54%2.56M45.13%-29.61M-25.31%-29.42M0.19%-23.66M-155.08%-16.48M-1,689.02%-53.96M
-Changes in the fair value of other assets 29.94%3.33M----117.32%5.09M----115.54%2.56M45.13%-29.61M-25.31%-29.42M0.19%-23.66M-155.08%-16.48M-1,689.02%-53.96M
Impairment and provision -1,791.84%-858.6K72.31%-414K119.88%136K121.86%146K--50.75K-457.84%-1.5M-2,211.70%-683.96K---668K-----168.00%-268K
-Other impairment is provision -1,791.84%-858.6K72.31%-414K119.88%136K121.86%146K--50.75K-457.84%-1.5M-2,211.70%-683.96K---668K-----168.00%-268K
Special items of operating profit -29.93%11.53M59.23%261.77M214.42%72.45M66.93%130.7M106.31%16.46M8.53%164.4M-10.29%23.04M263.51%78.3M-23.51%7.98M262.94%151.48M
Operating profit 1,263.69%82.56M271.70%710.07M67.74%-139.64M98.84%-2.96M96.05%-7.09M31.56%-413.55M15.62%-432.81M37.08%-255.92M-55.37%-179.67M30.30%-604.24M
Financing income -25.29%25.22M-----34.38%90.93M-----28.38%33.75M-----3.54%138.56M----2.15%47.13M----
Financing cost -6.40%-14.38M-60.21%-54.13M-102.91%-41.71M-160.11%-27.22M-161.10%-13.52M3.65%-33.79M32.62%-20.56M48.56%-10.47M50.03%-5.18M-105.74%-35.07M
Share of profit from joint venture company ----96.27%-196K----73.96%-400K-----7.35%-5.26M----26.40%-1.54M----49.54%-4.9M
Special items of earning before tax --325.04K----7,855.69%510.87K-------------100.07%-6.59K----4,957.94%31K----
Earning before tax 539.55%104.85M244.89%655.74M77.50%-64.18M88.59%-30.58M111.25%16.39M29.74%-452.59M47.10%-285.29M37.57%-267.92M-923.66%-145.66M27.92%-644.21M
Tax -----4,294.68%-11.56M-----17,331.03%-5.06M----81.56%-263K-------29K-------1.43M
After-tax profit from continuing operations 607.72%102.45M242.25%644.18M74.78%-71.95M86.70%-35.64M109.94%14.48M29.86%-452.86M47.09%-285.32M37.57%-267.95M-923.66%-145.66M27.76%-645.63M
Earning after tax 607.72%102.45M242.25%644.18M74.78%-71.95M86.70%-35.64M109.94%14.48M29.86%-452.86M47.09%-285.32M37.57%-267.95M-923.66%-145.66M27.76%-645.63M
Minority profit 3.47%-3.37M114.03%1.72M23.94%-7.54M9.24%-5.55M-7.22%-3.49M14.93%-12.22M-21.99%-9.91M12.35%-6.11M-78.67%-3.26M-101.42%-14.37M
Profit attributable to shareholders 488.93%105.82M245.81%642.47M76.61%-64.41M88.51%-30.09M112.62%17.97M30.20%-440.63M48.15%-275.41M37.98%-261.84M-1,047.82%-142.4M28.80%-631.26M
Basic earnings per share 500.00%0.06246.15%0.3875.00%-0.0487.50%-0.02112.50%0.0129.73%-0.2648.39%-0.1636.00%-0.16-700.00%-0.0838.33%-0.37
Diluted earnings per share 500.00%0.06246.15%0.3875.00%-0.0487.50%-0.02112.50%0.0129.73%-0.2648.39%-0.1636.00%-0.16-700.00%-0.0838.33%-0.37
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKASCAS (2007)HKAS
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Ernst & Young Huaming Accounting Firm (Special General Partnership)------Ernst & Young Huaming Accounting Firm (Special General Partnership)------Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -